ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 888

Prevalence of Takayasu Arteritis in Young Women Presenting with Acute Ischemic Heart Disease

Giulio Cavalli, Alessandro Tomelleri, Elena Baldissera and Lorenzo Dagna, Internal Medicine and Clinical Immunology, Vita-Salute San Raffaele University, Milan, Italy

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Cardiovascular disease, Critical care, Myocardial involvement, takayasu arteritis and vasculitis

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 13, 2016

Title: Vasculitis - Poster I: Large Vessel Vasculitis and Polymyalgia Rheumatica

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Ischemic heart disease (IHD) is classically considered a disease of older men. However, 10% of myocardial infarctions occur in patients aged <45; also, in up to 25% of cases, these young patients are females. Classic atherosclerosis represents the most common etiology in young patients with IHD; additional causes include coronary vasospasm, coronary artery dissection, or vasculitis. Takayasu arteritis (TA) is a rare, large vessel vasculitis characterized by granulomatous inflammation of the aorta and its major branches, usually occurring in female patients aged ≤40. Purpose of this study was to evaluate the prevalence of TA in young women presenting with acute IHD in the Emergency Department.

Methods: We evaluated the hospital records of 172,790 consecutive young female patients (aged <45), who accessed the Emergency Department of our institution, a University Hospital serving a population of 1.5 million, over 8 consecutive years (2007-2015). The diagnosis at discharge was confirmed by either outpatient clinic or a telephone interview. Diagnosis of TA was established based on the 1990 ACR criteria.

Results: We identified 2,090 women aged <45 who presented with chest pain, dyspnea, palpitations, angina, heart failure, or cardiac arrest. Of these patients, 40 had IHD, as confirmed by elevated serum troponin T and compatible electrocardiographic changes. Seven additional patients, who died either before or shortly after accessing the Urgent Care department and in whom autopsy was not performed, were excluded from the study since their cause of death was not univocally identifiable. The etiology of IHD was ‘classic’ atherosclerosis in 24 cases, TA in 4 cases, vasospasm and sympathomimetic drug abuse in 3 cases each, coronary artery dissection and microvascular angina in 2 cases each, Takotsubo and radiation-induced cardiomyopathy in 1 case each.

Conclusion: In spite of an extremely low incidence in the general population (1-3 new cases/million/year in Europe or the United States), TA accounted for 10% of cases of acute IHD in female patients aged <45 in our study group. Since our Institution serves a population of 1.5 million, and coronary involvement may appear in up to a third of TA patients, the number of observed cases is compatible with the a priori expectations based on TA estimated incidence. Although ‘classic’ atherosclerosis remains the leading cause of IHD, in our study cohort TA was more frequent a cause than vasospasm and drug abuse. This finding is important, as while the latter two etiologies are commonly considered in young patients with cardiac ischemia, TA is very likely to be overlooked. Our data indicate that TA is not infrequent in younger females presenting with acute IHD. The development of TA in a young woman marks the onset of a severe, chronic disease characterized by recurrences and significant morbidity and mortality in the most productive years of life. Thus, it is crucial that a diagnosis of TA is not overlooked in a young woman presenting with IHD, in order to provide optimal care of the patient besides the management of the acute event.


Disclosure: G. Cavalli, None; A. Tomelleri, None; E. Baldissera, None; L. Dagna, None.

To cite this abstract in AMA style:

Cavalli G, Tomelleri A, Baldissera E, Dagna L. Prevalence of Takayasu Arteritis in Young Women Presenting with Acute Ischemic Heart Disease [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/prevalence-of-takayasu-arteritis-in-young-women-presenting-with-acute-ischemic-heart-disease/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/prevalence-of-takayasu-arteritis-in-young-women-presenting-with-acute-ischemic-heart-disease/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology